mGluR
The mGluR (metabotropic glutamate receptor) is a group C GPCR and is active through an indirect metabotropic process.
Products Related to mGluR (123)
- GC16172MPEP HydrochlorideCAS: 219911-35-0Purity: >98.00%
MPEP Hydrochloride is a noncompetitive, selective, potent, orally active and systemically active mGlu5 receptor antagonist, with an IC 50 of 36nM for completely inhibiting quisqualate-stimulated phosphoinositide (PI) hydrolysis.
- GC17217JNJ 16259685CAS: 409345-29-5Purity: >98.00%
JNJ 16259685 is a potent and selective mGlu1 receptor antagonist with an IC 50 value of 19nM.
- GC17823L-Cysteinesulfinic acidCAS: 1115-65-7Purity: >98.00%
L-Cysteinesulfinic acid is an endogenous sulfur-containing excitatory amino acid, and an intermediate in the metabolic conversion of cysteine to taurine. L-Cysteinesulfinic acid acts as an agonist of NMDA receptors and mGlu receptors, and is applied in research on glutamatergic neurotransmission, taurine biosynthesis and central cardiovascular regulation.
- GC17963CHPG Sodium saltCAS: 1303993-73-8Purity: >99.50%
CHPG Sodium salt is a selective metabotropic glutamate receptor 5 (mGlu5) agonist.
- GC18412VU0409551 (JNJ-46778212)CAS: 1363281-27-9Purity: >99.50%
VU0409551 (JNJ-46778212) is a potent and selective biased positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGlu 5 PAM; EC 50 =260nM).
- GC19207JNJ-42153605CAS: 1254977-87-1Purity: >99.00%
JNJ-42153605 is a positive allosteric modulator of the metabotropic glutamate 2 (mGlu2) receptor with an EC50 of 17 nM.
- GC30303Mavoglurant racemate (AFQ-056 racemate)CAS: 1636881-61-2Purity: >98.50%
Mavoglurant racemate (AFQ-056 racemate) (AFQ-056 racemate) is the racemate of Mavoglurant.
- GC30778Mavoglurant (AFQ056)CAS: 543906-09-8Purity: >99.50%
Mavoglurant (AFQ056) is a structurally selective, non-competitive, orally active antagonist of the metabotropic glutamate receptor 5 (mGluR5), with an IC 50 value of 30nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC13426 | CPPHA | 693288-97-0 | >98% | |
A positive allosteric modulator of the mGluR5 | ||||
| GC13962 | VU 0361737 | 1161205-04-4 | >99.50% | |
MGlu4 receptor allosteric modulator | ||||
| GC14036 | ACPT-II | 195209-04-2 | >98% | |
metabotropic receptor antagonist | ||||
| GC14555 | LY341495 | 201943-63-7 | >98.50% | |
Selective antagonist of mGluR2 and mGluR3 | ||||
| GC15992 | Lu AF21934 | 1445605-23-1 | >99.00% | |
positive allosteric modulator of mGlu4 receptors | ||||
| GC16150 | VU 0364439 | 1246086-78-1 | >98.50% | |
Positive allosteric mGluR-4 modulator | ||||
| GC16172 | MPEP Hydrochloride | 219911-35-0 | >98.00% | |
MPEP Hydrochloride is a noncompetitive, selective, potent, orally active and systemically active mGlu5 receptor antagonist, with an IC 50 of 36nM for completely inhibiting quisqualate-stimulated phosphoinositide (PI) hydrolysis. | ||||
| GC16349 | (S)-MCPG | 150145-89-4 | >98.50% | |
mGluR antagonist | ||||
| GC16523 | Dipraglurant | 872363-17-2 | >99.50% | |
| GC17185 | MSOP | 66515-29-5 | >98.00% | |
group III metabotropic glutamate receptor antagonist | ||||
| GC17217 | JNJ 16259685 | 409345-29-5 | >98.00% | |
JNJ 16259685 is a potent and selective mGlu1 receptor antagonist with an IC 50 value of 19nM. | ||||
| GC17383 | PHCCC | 179068-02-1 | >98.00% | |
PHCCC is a group I mGluR antagonist with an IC 50 value of 3μM. | ||||
| GC17401 | RG7090 | 802906-73-6 | >98.00% | |
RG7090 (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM. | ||||
| GC17823 | L-Cysteinesulfinic acid | 1115-65-7 | >98.00% | |
L-Cysteinesulfinic acid is an endogenous sulfur-containing excitatory amino acid, and an intermediate in the metabolic conversion of cysteine to taurine. L-Cysteinesulfinic acid acts as an agonist of NMDA receptors and mGlu receptors, and is applied in research on glutamatergic neurotransmission, taurine biosynthesis and central cardiovascular regulation. | ||||
| GC17932 | L-AP4 | 23052-81-5 | >99.00% | |
group III metabotropic glutamate receptor agonist | ||||
| GC17963 | CHPG Sodium salt | 1303993-73-8 | >99.50% | |
CHPG Sodium salt is a selective metabotropic glutamate receptor 5 (mGlu5) agonist. | ||||
| GC18120 | XAP044 | 196928-50-4 | >98.00% | |
XAP044 is a potent mGlu7 selective antagonist, with an IC 50 value of 5.5μM. | ||||
| GC18412 | VU0409551 (JNJ-46778212) | 1363281-27-9 | >99.50% | |
VU0409551 (JNJ-46778212) is a potent and selective biased positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGlu 5 PAM; EC 50 =260nM). | ||||
| GC19207 | JNJ-42153605 | 1254977-87-1 | >99.00% | |
JNJ-42153605 is a positive allosteric modulator of the metabotropic glutamate 2 (mGlu2) receptor with an EC50 of 17 nM. | ||||
| GC19381 | VU6005649 | 2137047-43-7 | >98.50% | |
VU6005649 is a CNS penetrant mGlu7/8 receptor agonist with EC50s of 0.65 uM and 2.6 uM for mGlu7 receptor and mGlu8 receptor, respectively. | ||||
| GC30224 | FPTQ | 864863-72-9 | >99.50% | |
FPTQ is potent mGluR1 antagonist with IC50 values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively. | ||||
| GC30303 | Mavoglurant racemate (AFQ-056 racemate) | 1636881-61-2 | >98.50% | |
Mavoglurant racemate (AFQ-056 racemate) (AFQ-056 racemate) is the racemate of Mavoglurant. | ||||
| GC30778 | Mavoglurant (AFQ056) | 543906-09-8 | >99.50% | |
Mavoglurant (AFQ056) is a structurally selective, non-competitive, orally active antagonist of the metabotropic glutamate receptor 5 (mGluR5), with an IC 50 value of 30nM. | ||||
| GC30793 | ADX88178 | 1235318-89-4 | >99.50% | |
ADX88178 is a potent metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) with an EC50 of 4 nM for human mGluR4. | ||||
